Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review-Reference-Cited by-同舟云学术

Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review

Published:2019-08-13 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Militello Anna Maria,Zielli Teresa,Boggiani Daniela,Michiara Maria,Naldi Nadia,Bortesi Beatrice,Zanelli Paola,Uliana Vera,Giuliotti Sara,Musolino Antonino

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference49 articles.

1. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years;Malone;Cancer Res,2006

2. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations;Rennert;N Engl J Med.,2007

3. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA);Mavaddat;Cancer Epidemiol Biomarkers Prev.,2012

4. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study;Goodwin;J Clin Oncol.,2012

5. Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features;Tung;Breast Cancer Res.,2010

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of combined use of ribociclib with PARP1 inhibitor on cell kinetics in breast cancer;Oncology Letters;2024-04-03

2. CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial;The Oncologist;2024-01-04

3. Mahanine mediated therapeutic inhibition of estrogen receptor-α and CDK4/6 expression, decipher the chemoprevention-signaling cascade in preclinical model of breast cancer;Journal of Ethnopharmacology;2024-01

4. Visualization of breast cancer-related protein synthesis from the perspective of bibliometric analysis;European Journal of Medical Research;2023-10-27

5. Beyond PARP Inhibitors in Advanced Breast Cancer Patients with Germline BRCA1/2 Mutations: Focus on CDK4/6-Inhibitors and Data Review on Other Biological Therapies;Cancers;2023-06-23